Organometallic anticancer compounds
The quest for alternative drugs to the well-known cisplatin and its derivatives, which are still
used in more than 50% of the treatment regimes for patients suffering from cancer, is highly …
used in more than 50% of the treatment regimes for patients suffering from cancer, is highly …
Organometallic and coordination rhenium compounds and their potential in cancer therapy
EB Bauer, AA Haase, RM Reich, DC Crans… - Coordination Chemistry …, 2019 - Elsevier
This review focuses on cytotoxic rhenium compounds in terms of IC 50 values, their mode of
action in biological systems and their status in clinical trials. Biological studies of different …
action in biological systems and their status in clinical trials. Biological studies of different …
Underestimated potential of organometallic rhenium complexes as anticancer agents
A Leonidova, G Gasser - ACS chemical biology, 2014 - ACS Publications
In the recent years, organometallic compounds have become recognized as promising anti-
cancer drug candidates. While radioactive 186/188Re compounds are already used in …
cancer drug candidates. While radioactive 186/188Re compounds are already used in …
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan, M Melchart, A Habtemariam… - Chemical …, 2005 - pubs.rsc.org
Our work has shown that certain ruthenium (II) arene complexes exhibit promising
anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their …
anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their …
Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma
Combination therapy targeting both tumor growth and vascularization is considered to be a
cornerstone for colorectal carcinomas (CRC) treatment. However, the major obstacles of …
cornerstone for colorectal carcinomas (CRC) treatment. However, the major obstacles of …
Necroptosis-inducing rhenium (V) oxo complexes
Rhenium (V) oxo complexes of general formula [ReO (OMe)(N^ N) Cl2], where N^ N= 4, 7-
diphenyl-1, 10-phenanthroline, 1, or 3, 4, 7, 8-tetramethyl-1, 10-phenanthroline, 2, effectively …
diphenyl-1, 10-phenanthroline, 1, or 3, 4, 7, 8-tetramethyl-1, 10-phenanthroline, 2, effectively …
A Deadly Organometallic Luminescent Probe: Anticancer Activity of a ReI Bisquinoline Complex
I Kitanovic, S Can, H Alborzinia… - … A European Journal, 2014 - Wiley Online Library
The photophysical properties of [Re (CO) 3 (l‐N3)] Br (l‐N3= 2‐azido‐N, N‐bis [(quinolin‐2‐
yl) methyl] ethanamine), which could not be localized in cancer cells by fluorescence …
yl) methyl] ethanamine), which could not be localized in cancer cells by fluorescence …
Tricarbonylrhenium (I) complexes of phosphine-derivatized amines, amino acids and a model peptide: structures, solution behavior and cytotoxicity
J Zhang, JJ Vittal, W Henderson, JR Wheaton… - Journal of …, 2002 - Elsevier
Modified Mannich reactions of amines, amino acids and a model peptide with Ph2PH and
CH2O gave bis (diphenylphosphinomethyl) amines (Ph2PCH2) 2NR [R= Ph (1) …
CH2O gave bis (diphenylphosphinomethyl) amines (Ph2PCH2) 2NR [R= Ph (1) …
Dinuclear Rhenium (I) Tricarbonyl Complexes as Anticancer Drug Candidates
N Montesdeoca, RL Borkar… - … A European Journal, 2024 - Wiley Online Library
Cancer is one of the deadliest diseases worldwide. Chemotherapy remains one of the most
dominant forms for anticancer treatment. Despite their clinical success, the used …
dominant forms for anticancer treatment. Despite their clinical success, the used …
Toward Novel DNA Binding Metal Complexes: Structure and Basic Kinetic Data of [M(9MeG)2(CH3OH)(CO)3]+ (M = 99Tc, Re)
To study the interaction of the fac-[M (CO) 3]+ moiety (M= 99mTc, 188Re) with DNA bases,
we reacted [M (OH2) 3 (CO) 3]+ with 9-methylguanine (9-MeG), guanosine (G), and 2 …
we reacted [M (OH2) 3 (CO) 3]+ with 9-methylguanine (9-MeG), guanosine (G), and 2 …